Concepedia

Nathaly Anto-Michel

NA

Statistics

Publications

8

Citations

495

H-Index

8

Active since

2015

Affiliations

University of Freiburg(Current)

Universitäts-Herzzentrum Freiburg-Bad Krozingen

Medical University of Graz

University Medical Center Freiburg

Brigham and Women's Hospital

Nathaly Anto-Michel is an author at University of Freiburg specializing in cardiovascular pharmacology, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2015–2021

8

Publications

8

Nicotinamide for the treatment of heart failure with preserved ejection fraction

Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser et al. · Science Translational Medicine · 2021 · 192 citations · Full text

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense

Dennis Wolf, Nathaly Anto-Michel, Hermann Blankenbach et al. · Nature Communications · 2018 · 100 citations · Full text

Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice

Jan Pennig, Philipp Scherrer, Mark Colin Gissler et al. · Scientific Reports · 2019 · 79 citations · Full text

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran

Christoph B. Olivier, Patrick Weik, Melanie Meyer et al. · Thrombosis Research · 2015 · 38 citations

, , +10

Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression

Alexandra Lindau, Carmen Härdtner, Sonja Hergeth et al. · Basic Research in Cardiology · 2016 · 38 citations · Full text

1–5 of 8